Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 11, 2011, Pages 2512-2524

  Xi, Lei ^a   Zhu, Shu Guang ^a   Hobbs, Daniel C ^a   Kukreja, Rakesh C ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2D DIGE; Antioxidant; Cardioprotection; Cardiotoxicity; Doxorubicin; Nitrate; Proteomics

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; ANTIOXIDANT; CARDIOTONIC AGENT; CARDIOTOXIN; DOXORUBICIN; NITRATE; NITRIC OXIDE; PEROXIREDOXIN; PEROXIREDOXIN 3; SUPEROXIDE DISMUTASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HEART; HEART MUSCLE CELL; MALE; MASS SPECTROMETRY; METABOLISM; MORTALITY; MOUSE; OXIDATIVE STRESS; PROTEOMICS; SURVIVAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; CARDIOMYOPATHIES; CARDIOTONIC AGENTS; CARDIOTOXINS; DOXORUBICIN; HEART; MALE; MICE; MYOCYTES, CARDIAC; NITRATES; NITRIC OXIDE; OXIDATIVE STRESS; PEROXIREDOXIN III; PEROXIREDOXINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUPEROXIDE DISMUTASE; SURVIVAL;

ANIMALIA; MUS;

EID: 80054906010     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01257.x     Document Type: Article

References (42)

1. Bristow MR, Mason JW, Billingham ME, et al Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med. 1978; 88: 168-75.
2. Steinherz LJ, Steinherz PG, Tan C. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. Med Pediatr Oncol. 1995; 24: 352-61.
3. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998; 339: 900-5.
4. Thompson KL, Rosenzweig BA, Zhang J, et al Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats. Cancer Chemother Pharmacol. 2010; 66: 303-14.
5. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol. 2001; 33: 1897-918.
6. Ferdinandy P, Appelbaum Y, Csonka C, et al Role of nitric oxide and TPEN, a potent metal chelator, in ischaemic and reperfused rat isolated hearts. Clin Exp Pharmacol Physiol. 1998; 25: 496-502.
7. Varga E, Bodi A, Ferdinandy P, et al The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: a link between cardiac function and nitric oxide production. J Cardiovasc Pharmacol. 1999; 34: 711-7.
8. Xi L, Jarrett NC, Hess ML, et al Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. Circulation. 1999; 99: 2157-63.
9. Webb A, Bond R, McLean P, et al Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci USA. 2004; 101: 13683-8.
10. Cosby K, Partovi KS, Crawford JH, et al Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003; 9: 1498-505.
11. Bryan NS, Calvert JW, Elrod JW, et al Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA. 2007; 104: 19144-9.
12. Duranski MR, Greer JJ, Dejam A, et al Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest. 2005; 115: 1232-40.
13. Tsuchiya K, Kanematsu Y, Yoshizumi M, et al Nitrite is an alternative source of NO in vivo. Am J Physiol Heart Circ Physiol. 2005; 288: H2163-70.
14. Kapil V, Milsom AB, Okorie M, et al Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension. 2010; 56: 274-81.
15. Zhu SG, Das A, Xi L, et al Dietary supplementation of nitrate protects against doxorubicin-induced ventricular dysfunction and cardiomyocyte cell death in mice. Circulation. 2008; 118: S945 (abstract).
16. Chen Q, Zhu SG, Lesnefsky EJ, et al Chronic dietary supplementation of nitrate prevents doxorubicin-induced cardiac mitochondrial damage. Circulation. 2009; 120: S867 (abstract).
17. Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem. 2005; 382: 669-78.
18. Moore JC, Fu J, Chan YC, et al Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Biochem Biophys Res Commun. 2008; 372: 553-8.
19. Koka S, Das A, Zhu SG, et al Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect. J Pharmacol Exp Ther. 2010; 334: 1023-30.
20. Merten KE, Feng W, Zhang L, et al Modulation of cytochrome C oxidase-va is possibly involved in metallothionein protection from doxorubicin cardiotoxicity. J Pharmacol Exp Ther. 2005; 315: 1314-9.
21. Yen HC, Oberley TD, Vichitbandha S, et al The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest. 1996; 98: 1253-60.
22. Yen HC, Oberley TD, Gairola CG, et al Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch Biochem Biophys. 1999; 362: 59-66.
23. Chen Q, Zhu S-G, Lesnefsky EJ, et al Chronic dietary supplementation of nitrate decreases doxorubicin-induced oxidative stress in cardiac mitochondria and tissues. Circulation. 2010; 122, A15894 (abstract).
24. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med. 2005; 38: 1543-52.
25. Kang SW, Rhee SG, Chang TS, et al 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol Med. 2005; 11: 571-8.
26. Plaisant F, Clippe A, Vander SD, et al Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice. Free Radic Biol Med. 2003; 34: 862-72.
27. Banmeyer I, Marchand C, Clippe A, et al Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide. FEBS Lett. 2005; 579: 2327-33.
28. Trujillo M, Clippe A, Manta B, et al Pre-steady state kinetic characterization of human peroxiredoxin 5: taking advantage of Trp84 fluorescence increase upon oxidation. Arch Biochem Biophys. 2007; 467: 95-106.
29. Abbas K, Breton J, Picot CR, et al Signaling events leading to peroxiredoxin 5 up-regulation in immunostimulated macrophages. Free Radic Biol Med. 2009; 47: 794-802.
30. Ito H, Miller SC, Billingham ME, et al Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci USA. 1990; 87: 4275-9.
31. Yi X, Bekeredjian R, DeFilippis NJ, et al Transcriptional analysis of doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol. 2006; 290: H1098-102.
32. Chen Y, Daosukho C, Opii WO, et al Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice. Free Radic Biol Med. 2006; 41: 1470-7.
33. Ohyama K, Tomonari M, Ichibangase T, et al A toxicoproteomic study on cardioprotective effects of pre-administration of docetaxel in a mouse model of adriamycin-induced cardiotoxicity. Biochem Pharmacol. 2010; 80: 540-7.
34. Vedam K, Nishijima Y, Druhan LJ, et al Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice. Am J Physiol Heart Circ Physiol. 2010; 298: H1832-41.
35. Venkatakrishnan CD, Tewari AK, Moldovan L, et al Heat shock protects cardiac cells from doxorubicin-induced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27. Am J Physiol Heart Circ Physiol. 2006; 291: H2680-91.
36. Xie L, Terrand J, Xu B, et al Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation. Cardiovasc Res. 2010; 87: 628-35.
37. Ayebo A, Kross BC, Vlad M, et al Infant Methemoglobinemia in the Transylvania Region of Romania. Int J Occup Environ Health. 1997; 3: 20-9.
38. McKnight GM, Duncan CW, Leifert C, et al Dietary nitrate in man: friend or foe Br J Nutr. 1999; 81: 349-58.
39. Hord NG, Tang Y, Bryan NS. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr. 2009; 90: 1-10.
40. 2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol. 2009; 107: 1144-55.
41. Larsen FJ, Weitzberg E, Lundberg JO, et al Dietary nitrate reduces maximal oxygen consumption while maintaining work performance in maximal exercise. Free Radic Biol Med. 2010; 48: 342-7.
42. Carlstrom M, Larsen FJ, Nystrom T, et al Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc Natl Acad Sci USA. 2010; 107: 17716-20.